Journal article
Impact of Methylprednisolone on Postoperative Quality of Recovery and Delirium in the Steroids in Cardiac Surgery Trial: A Randomized, Double-blind, Placebo-controlled Substudy
CF Royse, L Saager, R Whitlock, J Ou-Young, A Royse, J Vincent, PJ Devereaux, A Kurz, A Awais, K Panjasawatwong, DI Sessler
Anesthesiology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2017
Abstract
Background: Inflammation after cardiopulmonary bypass may contribute to postoperative delirium and cognitive dysfunction. The authors evaluated the effect of high-dose methylprednisolone to suppress inflammation on the incidence of delirium and postoperative quality of recovery after cardiac surgery. Methods: Five hundred fifty-five adults from three hospitals enrolled in the randomized, double-blind Steroids in Cardiac Surgery trial were randomly allocated to placebo or 250 mg methylprednisolone at induction and 250 mg methylprednisolone before cardiopulmonary bypass. Each completed the Postoperative Quality of Recovery Scale before surgery and on days 1, 2, and 3 and 1 and 6 months after s..
View full abstractGrants
Funding Acknowledgements
This study was a substudy to the Steriods In caRdiac Surgery (SIRS) study and not separately funded. SIRS was funded by the Canadian Institutes of Health Research (Ottawa, Ontario, Canada).